DOCSLIB.ORG

WOMEN in REPRODUCTIVE SCIENCE: Lessons From

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WOMEN in REPRODUCTIVE SCIENCE: Lessons From 158 3 REPRODUCTIONFOCUS REVIEW WOMEN IN REPRODUCTIVE SCIENCE Lessons from bioengineering the ovarian follicle: a personal perspective Teresa K Woodruff Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Correspondence should be addressed to T K Woodruff; Email: [email protected] This paper forms part of a focus section on Women in Reproductive Science. The guest editor for this section was Professor Marilyn Renfree, Ian Potter Chair of Zoology, School of BioSciences, The University of Melbourne, Victoria, Australia Abstract The ovarian follicle and its maturation captivated my imagination and inspired my scientific journey – what we know now about this remarkable structure is captured in this invited review. In the past decade, our knowledge of the ovarian follicle expanded dramatically as cross-disciplinary collaborations brought new perspectives to bear, ultimately leading to the development of extragonadal follicles as model systems with significant clinical implications. Follicle maturation in vitro in an ‘artificial’ ovary became possible by learning what the follicle is fundamentally and autonomously capable of – which turns out to be quite a lot. Progress in understanding and harnessing follicle biology has been aided by engineers and materials scientists who created hardware that enables tissue function for extended periods of time. The EVATAR system supports extracorporeal ovarian function in an engineered environment that mimics the endocrine environment of the reproductive tract. Finally, applying the tools of inorganic chemistry, we discovered that oocytes require zinc to mature over time – a truly new aspect of follicle biology with no antecedent other than the presence of zinc in sperm. Drawing on the tools and ideas from the fields of bioengineering, materials science and chemistry unlocked follicle biology in ways that we could not have known or even predicted. Similarly, how today’s basic science discoveries regarding ovarian follicle maturation are translated to improve the experience of tomorrow’s patients is yet to be determined. Reproduction (2019) 158 F113–F126 Introduction needing to be purified by each lab. The chemically laborious Maxim–Gilbert sequencing method was also Sitting proudly on my desk is a first edition of Regnier giving way to the enzymatically elegant Sanger dideoxy De Graaf’s treatise on the ovarian follicle (de Graaf sequencing method. Within 4 years of publishing the rat 1672), given to me by my great friend Najiba Lalou on inhibin sequence, graduate students like me, would no the occasion of my investiture as the Thomas J Watkins longer be cloning, sequencing, and publishing genetic Chair of Obstetrics and Gynecology at Northwestern data – those tasks would become the purview of The University (Box 1). As strange as it may sound, I have Human Genome Project. loved the ovarian follicle and its cyclical rhythm since A little over a decade passed in which I continued my first introduction to the structure in graduate school. my work on the inhibins and activins, their cyclical My PhD thesis advisor, Dr Kelly Mayo, had cloned a regulation in and release from the ovarian follicle, and gene expressed by the human ovarian follicle, the inhibin their function in the reproductive axis. I collaborated α-subunit (Mayo et al. 1986). My task was to clone the with Dr Tom Thompson to solve the crystal structure inhibin subunits from rats and sequence the associated of activin with its receptor and binding proteins, genes, and then determine their molecular regulation elucidating key functional domains and shedding during the reproductive cycle (Woodruff et al. 1987, light on how the inhibin and activin ligands may have 1988, 1989, 1991, D’Agostino et al. 1989, Woodruff & co-evolved (Thompson et al. 2003, 2005, Cook et al. Mayo 1990, Makanji et al. 2014b). At the time, cloning 2005, Lin et al. 2006, 2011, Lerch et al. 2007a,b, Zhu of genes was reaching a fever pitch, with reagents like et al. 2010). Having the right tools at the right time is restriction enzymes available for purchase rather than a critical part of the advancement of science, and a © 2019 Society for Reproduction and Fertility https://doi.org/10.1530/REP -19-0190 ISSN 1470–1626 (paper) 1741–7899 (online) Online version via https://rep.bioscientifica.com Downloaded from Bioscientifica.com at 09/30/2021 03:49:35PM via free access -19-0190 F114 T K Woodruff Box 1 Teresa K Woodruff PhD is the Dean and Associate Provost for Graduate Education in The Graduate School at Northwestern University. She is also the Thomas J Watkins Professor of Obstetrics & Gynecology, the Vice Chair for Research and the Chief of the Division of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology, Feinberg School of Medicine. She is the Professor of Molecular Biosciences in the Weinberg College of Arts and Sciences and Professor of Biomedical Engineering in the McCormick School of Engineering. She is the Director of the Center for Reproductive Science (CRS), Founder and Director of the Women’s Health Research Institute (WHRI) and Director of the Oncofertility Consortium. She is an internationally recognized expert in ovarian biology and, in 2006, coined the term ‘oncofertility’ to describe the merging of two fields: oncology and fertility. She now heads the Oncofertility Consortium, an interdisciplinary team of biomedical and social scientist experts from across the country. She has been active in education not only at the professional level but also with high school students. In 2011, she was awarded the Presidential Award for Excellence in Science Mentoring in an oval office ceremony by President Obama. Prof Woodruff holds more than 10 U.S. Patents, and was elected to the National Academy of (2017). Her honors include a Guggenheim Fellowship (2017), the Society for Endocrinology Transatlantic Medal (2017), a Leadership Award from the Endocrine Society (2017) and the Mentor of the Year Award from the Society for the Study of Reproduction (2018). She has two honorary degrees, including one from the University of Birmingham, College of Medical Studies, UK (2016) and one from Bates College (2011). She is an elected member of the National Academy of Medicine (2018), a fellow of the American Institute of Medical and Biological Engineering (2017) and the American Association for the Advancement of Science (AAAS; 2005). She is past-president of the Endocrine Society and championed the new NIH policy that mandates the use of females in fundamental research. She currently serves as Editor-in-Chief of Endocrinology. She is civically active and is an elected member of The Economic Club of Chicago, The Chicago Network, a member of the Adler Planetary of Chicago Board of Trustees, and previously served on the school board of the Chicago-based Young Women’s Leadership Charter School. Some important articles Ma Y, Oliveira DFM, Woodruff TK & Uzzi B 2019 Women who win prizes get less money and prestige. Nature 565 287–288. (https://doi. org/10.1038/d41586-019-00091-3) Smith BM, Duncan FE, Ataman L, Smith K, Quinn GP, Chang RJ, Finlayson C, Orwig K, Valli-Pulaski H, Moravek MB et al. 2018 The National Physicians Cooperative: transforming fertility management in the cancer setting and beyond. Future Oncology 14 3059–3072. (https://doi. org/10.2217/fon-2018-0278) Laronda MM, Rutz AL, Xiao S, Whelan KA, Duncan FE, Roth EW, Woodruff TK & Shah RN 2017 A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice. Nature Communications 8 15261. (https://doi.org/10.1038/ncomms15261) Xiao S, Coppeta JR, Rogers HB, Isenberg BC, Zhu J, Olalekan SA, McKinnon KE, Dokic D, Rashedi AS, Haisenleder DJ et al. 2017 A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nature Communications 8 14584. (https://doi.org/10.1038/ ncomms14584) Duncan FE, Que EL, Zhang N, Feinberg EC, O’Halloran TV & Woodruff TK 2016 The zinc spark is an inorganic signature of human egg activation. Scientific Reports 6 24737. (https://doi.org/10.1038/srep24737) Zhang N, Duncan FE, Que EL, O’Halloran TV & Woodruff TK 2016 The fertilization-induced zinc spark is a novel biomarker of mouse embryo quality and early development. Scientific Reports 6 22772. (https://doi.org/10.1038/srep22772) Xiao S, Zhang J, Romero MM, Smith KN, Shea LD & Woodruff TK 2015b In vitro follicle growth supports human oocyte meiotic maturation. Scientific Reports 5 17323. (https://doi.org/10.1038/srep17323) Zhu J, Mishra RK, Schiltz GE, Makanji Y, Scheidt KA, Mazar AP & Woodruff TK 2015 Virtual High-Throughput Screening To Identify Novel Activin Antagonists. Journal of Medicinal Chemistry 58 5637–5648. (https://doi.org/10.1021/acs.jmedchem.5b00753) Kim AM, Vogt S, O’Halloran TV & Woodruff TK 2010 Zinc availability regulates exit from meiosis in maturing mammalian oocytes. Nature Chemical Biology 6 674–681. (https://doi.org/10.1038/nchembio.419) Woodruff TK, D’Agostino J, Schwartz NB & Mayo KE 1988 Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle. Science 239 1296–1299. (https://doi.org/10.1126/science.3125611) willingness to cross-disciplinary lines and be an early Ovarian follicle maturation is autonomous to adopter or even an inventor is a winning combination. the follicle Here I provide a bit of background on some of the essential tools that my lab has utilized or invented to The ovary can be seen as an artful box that holds learn more about the ovarian follicle and the ways in individual organs called follicles. Each follicle contains which follicles develop over reproductive time. These a single germ cell – the oocyte – and is responsible tools have been prismatic – they have allowed us to for production of the hormones necessary for oocyte peer through them as the light shines in, revealing maturation and for endocrine feedback to the higher multiple facets of follicle biology that feather out in a brain centers within the reproductive axis.
Load more

Recommended publications
  • 34 Annual Minisymposium on Reproductive Biology
    34th Annual Minisymposium on Reproductive Biology January 26th, 2015 Lurie Medical Research Center 303 E. Superior St, Northwestern University, Chicago, IL Sponsored by The Office of the President The Office of the Vice President for Research The Graduate School Table of Contents About the Center for Reproductive Science/Center Sponsored Awards ....................... 3 Minisymposium on Reproductive Biology Overview ................................................... 5 Neena B. Schwartz Lectureship in Reproductive Science ............................................. 7 Lectureship Recipient, Richard L. Stouffer, PhD .......................................................... 9 The Legacy of Dr. Constance Campbell ...................................................................... 11 Northwestern Alumni Speaker, David L. Keefe, MD .................................................. 13 Program for Minisymposium ....................................................................................... 15 ABSTRACTS: Oral Session .............................................................................................................. 17 Poster Sessions .......................................................................................................... 21 List of Presenters .......................................................................................................... 47 Acknowledgements ...................................................................................................... 49 Front cover photograph courtesy
    [Show full text]
  • Creating an Artificial 3-Dimensional Ovarian Follicle Culture System
    micromachines Article Creating an Artificial 3-Dimensional Ovarian Follicle Culture System Using a Microfluidic System Mae W. Healy 1,2, Shelley N. Dolitsky 1, Maria Villancio-Wolter 3, Meera Raghavan 3, Alexandra R. Tillman 3 , Nicole Y. Morgan 3, Alan H. DeCherney 1, Solji Park 1,*,† and Erin F. Wolff 1,4,† 1 Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA; [email protected] (M.W.H.); [email protected] (S.N.D.); [email protected] (A.H.D.); [email protected] (E.F.W.) 2 Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA 3 Trans-NIH Shared Resource on Biomedical Engineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA; [email protected] (M.V.-W.); [email protected] (M.R.); [email protected] (A.R.T.); [email protected] (N.Y.M.) 4 Pelex, Inc., McLean, VA 22101, USA * Correspondence: [email protected] † Solji Park and Erin F. Wolff are co-senior authors. Abstract: We hypothesized that the creation of a 3-dimensional ovarian follicle, with embedded gran- ulosa and theca cells, would better mimic the environment necessary to support early oocytes, both structurally and hormonally. Using a microfluidic system with controlled flow rates, 3-dimensional Citation: Healy, M.W.; Dolitsky, S.N.; two-layer (core and shell) capsules were created. The core consists of murine granulosa cells in Villancio-Wolter, M.; Raghavan, M.; 0.8 mg/mL collagen + 0.05% alginate, while the shell is composed of murine theca cells suspended Tillman, A.R.; Morgan, N.Y.; in 2% alginate.
    [Show full text]
  • Oogenesis [PDF]
    Oogenesis Dr Navneet Kumar Professor (Anatomy) K.G.M.U Dr NavneetKumar Professor Anatomy KGMU Lko Oogenesis • Development of ovum (oogenesis) • Maturation of follicle • Fate of ovum and follicle Dr NavneetKumar Professor Anatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Oogenesis • Site – ovary • Duration – 7th week of embryo –primordial germ cells • -3rd month of fetus –oogonium • - two million primary oocyte • -7th month of fetus primary oocyte +primary follicle • - at birth primary oocyte with prophase of • 1st meiotic division • - 40 thousand primary oocyte in adult ovary • - 500 primary oocyte attain maturity • - oogenesis completed after fertilization Dr Navneet Kumar Dr NavneetKumar Professor Professor (Anatomy) Anatomy KGMU Lko K.G.M.U Development of ovum Oogonium(44XX) -In fetal ovary Primary oocyte (44XX) arrest till puberty in prophase of 1st phase meiotic division Secondary oocyte(22X)+Polar body(22X) 1st phase meiotic division completed at ovulation &enter in 2nd phase Ovum(22X)+polarbody(22X) After fertilization Dr NavneetKumar Professor Anatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Dr Navneet Kumar Dr ProfessorNavneetKumar (Anatomy) Professor K.G.M.UAnatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Maturation of follicle Dr NavneetKumar Professor Anatomy KGMU Lko Maturation of follicle Primordial follicle -Follicular cells Primary follicle -Zona pallucida -Granulosa cells Secondary follicle Antrum developed Ovarian /Graafian follicle - Theca interna &externa -Membrana granulosa -Antrial
    [Show full text]
  • Harris' Neuroendocrine Revolution
    G FINK Of portal vessels and 226:2 T13–T24 Thematic Review self-priming 60 YEARS OF NEUROENDOCRINOLOGY MEMOIR: Harris’ neuroendocrine revolution: of portal vessels and self-priming Correspondence George Fink should be addressed to G Fink Florey Institute of Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Email Genetics Lane, Parkville, Victoria 3010, Australia george.fink@florey.edu.au or georgefi[email protected] Abstract Geoffrey Harris, while still a medical student at Cambridge, was the first researcher (1937) to Key Words provide experimental proof for the then tentative view that the anterior pituitary gland was " neurohormones controlled by the CNS. The elegant studies carried out by Harris in the 1940s and early 1950s, " hypophysial portal alone and in collaboration with John Green and Dora Jacobsohn, established that this control vessel blood was mediated by a neurohumoral mechanism that involved the transport by hypophysial " gonadotrophin-releasing hormone (GnRH) portal vessel blood of chemical substances from the hypothalamus to the anterior pituitary " self-priming effect of GnRH gland. The neurohumoral control of anterior pituitary secretion was proved by the isolation " oestrogen-induced and characterisation of the ‘chemical substances’ (mainly neuropeptides) and the finding that ovulatory GnRH surge Journal of Endocrinology these substances were released into hypophysial portal blood in a manner consistent with " oestrogen-induced increase their physiological functions. The new discipline of neuroendocrinology – the way that the in pituitary responsiveness brain controls endocrine glands and vice versa – revolutionised the treatment of endocrine to GnRH disorders such as growth and pubertal abnormalities, infertility and hormone-dependent tumours, and it underpins our understanding of the sexual differentiation of the brain and key aspects of behaviour and mental disorder.
    [Show full text]
  • Diagnostic Evaluation of the Infertile Female: a Committee Opinion
    Diagnostic evaluation of the infertile female: a committee opinion Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Diagnostic evaluation for infertility in women should be conducted in a systematic, expeditious, and cost-effective manner to identify all relevant factors with initial emphasis on the least invasive methods for detection of the most common causes of infertility. The purpose of this committee opinion is to provide a critical review of the current methods and procedures for the evaluation of the infertile female, and it replaces the document of the same name, last published in 2012 (Fertil Steril 2012;98:302–7). (Fertil SterilÒ 2015;103:e44–50. Ó2015 by American Society for Reproductive Medicine.) Key Words: Infertility, oocyte, ovarian reserve, unexplained, conception Use your smartphone to scan this QR code Earn online CME credit related to this document at www.asrm.org/elearn and connect to the discussion forum for Discuss: You can discuss this article with its authors and with other ASRM members at http:// this article now.* fertstertforum.com/asrmpraccom-diagnostic-evaluation-infertile-female/ * Download a free QR code scanner by searching for “QR scanner” in your smartphone’s app store or app marketplace. diagnostic evaluation for infer- of the male partner are described in a Pregnancy history (gravidity, parity, tility is indicated for women separate document (5). Women who pregnancy outcome, and associated A who fail to achieve a successful are planning to attempt pregnancy via complications) pregnancy after 12 months or more of insemination with sperm from a known Previous methods of contraception regular unprotected intercourse (1).
    [Show full text]
  • Social Freezing: Pressing Pause on Fertility
    International Journal of Environmental Research and Public Health Review Social Freezing: Pressing Pause on Fertility Valentin Nicolae Varlas 1,2 , Roxana Georgiana Bors 1,2, Dragos Albu 1,2, Ovidiu Nicolae Penes 3,*, Bogdana Adriana Nasui 4,* , Claudia Mehedintu 5 and Anca Lucia Pop 6 1 Department of Obstetrics and Gynaecology, Filantropia Clinical Hospital, 011171 Bucharest, Romania; [email protected] (V.N.V.); [email protected] (R.G.B.); [email protected] (D.A.) 2 Department of Obstetrics and Gynaecology, “Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu St., 020021 Bucharest, Romania 3 Department of Intensive Care, University Clinical Hospital, “Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu St., 020021 Bucharest, Romania 4 Department of Community Health, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania 5 Department of Obstetrics and Gynaecology, Nicolae Malaxa Clinical Hospital, 020346 Bucharest, Romania; [email protected] 6 Department of Clinical Laboratory, Food Safety, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; [email protected] * Correspondence: [email protected] (O.N.P.); [email protected] (B.A.N.) Abstract: Increasing numbers of women are undergoing oocyte or tissue cryopreservation for medical or social reasons to increase their chances of having genetic children. Social egg freezing (SEF) allows women to preserve their fertility in anticipation of age-related fertility decline and ineffective fertility treatments at older ages. The purpose of this study was to summarize recent findings focusing on the challenges of elective egg freezing.
    [Show full text]
  • The Reproductive System
    PowerPoint® Lecture Slides prepared by Meg Flemming Austin Community College C H A P T E R 19 The Reproductive System © 2013 Pearson Education, Inc. Chapter 19 Learning Outcomes • 19-1 • List the basic components of the human reproductive system, and summarize the functions of each. • 19-2 • Describe the components of the male reproductive system; list the roles of the reproductive tract and accessory glands in producing spermatozoa; describe the composition of semen; and summarize the hormonal mechanisms that regulate male reproductive function. • 19-3 • Describe the components of the female reproductive system; explain the process of oogenesis in the ovary; discuss the ovarian and uterine cycles; and summarize the events of the female reproductive cycle. © 2013 Pearson Education, Inc. Chapter 19 Learning Outcomes • 19-4 • Discuss the physiology of sexual intercourse in males and females. • 19-5 • Describe the age-related changes that occur in the reproductive system. • 19-6 • Give examples of interactions between the reproductive system and each of the other organ systems. © 2013 Pearson Education, Inc. Basic Reproductive Structures (19-1) • Gonads • Testes in males • Ovaries in females • Ducts • Accessory glands • External genitalia © 2013 Pearson Education, Inc. Gametes (19-1) • Reproductive cells • Spermatozoa (or sperm) in males • Combine with secretions of accessory glands to form semen • Oocyte in females • An immature gamete • When fertilized by sperm becomes an ovum © 2013 Pearson Education, Inc. Checkpoint (19-1) 1. Define gamete. 2. List the basic components of the reproductive system. 3. Define gonads. © 2013 Pearson Education, Inc. The Scrotum (19-2) • Location of primary male sex organs, the testes • Hang outside of pelvic cavity • Contains two chambers, the scrotal cavities • Wall • Dartos, a thin smooth muscle layer, wrinkles the scrotal surface • Cremaster muscle, a skeletal muscle, pulls testes closer to body to ensure proper temperature for sperm © 2013 Pearson Education, Inc.
    [Show full text]
  • Reproductive Cycles in Females
    MOJ Women’s Health Review Article Open Access Reproductive cycles in females Abstract Volume 2 Issue 2 - 2016 The reproductive system in females consists of the ovaries, uterine tubes, uterus, Heshmat SW Haroun vagina and external genitalia. Periodic changes occur, nearly every one month, in Faculty of Medicine, Cairo University, Egypt the ovary and uterus of a fertile female. The ovarian cycle consists of three phases: follicular (preovulatory) phase, ovulation, and luteal (postovulatory) phase, whereas Correspondence: Heshmat SW Haroun, Professor of the uterine cycle is divided into menstruation, proliferative (postmenstrual) phase Anatomy and Embryology, Faculty of Medicine, Cairo University, and secretory (premenstrual) phase. The secretory phase of the endometrium shows Egypt, Email [email protected] thick columnar epithelium, corkscrew endometrial glands and long spiral arteries; it is under the influence of progesterone secreted by the corpus luteum in the ovary, and is Received: June 30, 2016 | Published: July 21, 2016 an indicator that ovulation has occurred. Keywords: ovarian cycle, ovulation, menstrual cycle, menstruation, endometrial secretory phase Introduction lining and it contains the uterine glands. The myometrium is formed of many smooth muscle fibres arranged in different directions. The The fertile period of a female extends from the age of puberty perimetrium is the peritoneal covering of the uterus. (11-14years) to the age of menopause (40-45years). A fertile female exhibits two periodic cycles: the ovarian cycle, which occurs in The vagina the cortex of the ovary and the menstrual cycle that happens in the It is the birth and copulatory canal. Its anterior wall measures endometrium of the uterus.
    [Show full text]
  • Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity
    International Journal of Molecular Sciences Review Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity Hyun-Woong Cho, Sanghoon Lee * , Kyung-Jin Min , Jin Hwa Hong , Jae Yun Song, Jae Kwan Lee , Nak Woo Lee and Tak Kim Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul 02841, Korea; [email protected] (H.-W.C.); [email protected] (K.-J.M.); [email protected] (J.H.H.); [email protected] (J.Y.S.); [email protected] (J.K.L.); [email protected] (N.W.L.); [email protected] (T.K.) * Correspondence: [email protected]; Tel.: +82-2-920-6773 Received: 9 October 2020; Accepted: 20 October 2020; Published: 21 October 2020 Abstract: Due to improvements in chemotherapeutic agents, cancer treatment efficacy and cancer patient survival rates have greatly improved, but unfortunately gonadal damage remains a major complication. Gonadotoxic chemotherapy, including alkylating agents during reproductive age, can lead to iatrogenic premature ovarian insufficiency (POI), and loss of fertility. In recent years, the demand for fertility preservation has increased dramatically among female cancer patients. Currently, embryo and oocyte cryopreservation are the only established options for fertility preservation in women. However, there is growing evidence for other experimental techniques including ovarian tissue cryopreservation, oocyte in vitro maturation, artificial ovaries, stem cell technologies, and ovarian suppression. To prevent fertility loss in women with cancer, individualized fertility
    [Show full text]
  • Gore, Andrea C. (1)
    Last Updated 10-12-20 C.V. - Gore, Andrea C. (1) CURRICULUM VITAE Andrea C. Gore, Ph.D. Professor and Vacek Chair of Pharmacology Address The University of Texas at Austin Division of Pharmacology and Toxicology 107 W. Dean Keeton, Stop C0875, Room BME 3.510B Austin, TX 78712, USA Office phone: (512) 471-3669 Office fax: (512) 471-5002 Lab phone: (512) 471-6311 Lab fax: (512) 471-3589 email: [email protected] Gore Lab: https://sites.utexas.edu/gore/ Google Scholar: http://scholar.google.com/citations?user=iCgJEF0AAAAJ&hl=en My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/45448158/?sort=date &direction=ascending ORCID: 0000-0001-5549-6793 Education 1990 Ph.D., Neuroscience Training Program, December 1990 University of Wisconsin, Madison, WI Supervisor: Dr. Ei Terasawa Dissertation title: “The roles of norepinephrine and neuropeptide Y in the control of the onset of puberty in female rhesus monkeys” 1985 A.B., Biology (cum laude), June 1985 Princeton University, Princeton, NJ Undergraduate Thesis Supervisor: Dr. Robert D. Lisk Thesis title: “Male dominance status, female choice and mating success in golden hamsters” Professional Experience and Appointments 2014-present Professor and Vacek Chair of Pharmacology (tenured) Division of Pharmacology and Toxicology, College of Pharmacy; Institute for Neuroscience; Institute for Cellular and Molecular Biology The University of Texas at Austin, Austin, TX 2008-2014 Gustavus & Louise Pfeiffer Professor of Toxicology (tenured) Division of Pharmacology and Toxicology, College of Pharmacy; Institute for Neuroscience; Institute for Cellular and Molecular Biology The University of Texas at Austin, Austin, TX Professor, Behavioral Neurosciences (Dept.
    [Show full text]
  • Preservation of Fertility in Patients with Cancer (Review)
    ONCOLOGY REPORTS 41: 2607-2614, 2019 Preservation of fertility in patients with cancer (Review) SOFÍA DEL-POZO-LÉRIDA1, CRISTINA SALVADOR2, FINA MARTÍNEZ-SOLER3, AVELINA TORTOSA3, MANUEL PERUCHO4,5 and PEPITA GIMÉNEZ-BONAFÉ1 1Department of Physiological Sciences, Physiology Unit, Faculty of Medicine and Health Sciences, Bellvitge Campus, Universitat de Barcelona, IDIBELL, L'Hospitalet del Llobregat, 08907 Barcelona; 2Department of Gynecology, Gynecological Endocrinology and Reproduction Unit, Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona; 3Department of Basic Nursing, Faculty of Medicine and Health Sciences, Universitat de Barcelona, IDIBELL, L' Hospital et del Llobregat, 08907 Barcelona, Spain; 4Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, CA 92037, USA; 5Program of Predictive and Personalized Medicine of Cancer (PMPPC), of the Research Institute Germans Trias i Pujol (IGTP), Badalona, 08916 Barcelona, Spain Received January 18, 2019; Accepted March 6, 2019 DOI: 10.3892/or.2019.7063 Abstract. Survival rates in oncological patients have been techniques evaluated. Emerging techniques are promising, steadily increasing in recent years due to the greater effec- such as the cryopreservation in orthotopic models of ovarian tiveness of novel oncological treatments, such as radio- and or testicle tissues, artificial ovaries, or in vitro culture prior chemotherapy. However, these treatments impair the reproduc- to the autotransplantation of cryopreserved tissues. However, tive ability of patients, and may cause premature ovarian failure oocyte vitrification for female patients and sperm banking for in females and azoospermia in males. Fertility preservation male patients are considered the first line fertility preserva- in both female and male oncological patients is nowadays tion option at the present time for cancer patients undergoing possible and should be integrated as part of the oncological treatment.
    [Show full text]
  • Evaluation of the Infertile Female
    REVIEW ARTICLE Indian Journal of Clinical Practice, Vol. 31, No. 1, June 2020 Evaluation of the Infertile Female GARIMA KACHHAWA*, ANJU SINGH* ABSTRACT Infertility is defined as failure to conceive after 1 year of regular unprotected intercourse and is estimated to affect 10-15% of couples worldwide. Evaluation of the female partner is started if she fails to achieve pregnancy after 12 months or more of regular unprotected intercourse. This article provides a comprehensive review of the evaluation of a woman with infertility. We discuss the history and physical examination, evaluation of ovulatory function, tubal and peritoneal factors, uterine factors, cervical factors and ovarian reserve testing in detail. Keywords: Female infertility, ovulatory dysfunction, uterine factors, tubal and peritoneal factors, cervical factors, ovarian reserve test, basal body temperature nfertility is defined as failure to conceive after 1 year HISTORY AND EXAMINATION of regular unprotected intercourse. It affects 10-15% of couples worldwide. Female factor is responsible Both the partners should be made aware of underlying I causes of infertility, components of basic evaluation and for infertility in 35-40% of couples. Among females, the major causes of infertility include ovulatory encouraged for simultaneous testing. dysfunction (30-40%), tubal and peritoneal pathology Diagnostic evaluation should begin with thorough (30-40%), cervical factor (3%), uterine factor (rare) and history and physical examination. History taking of unexplained (10%) (Fig. 1). infertile partner must include the following: Usually, we start evaluation of female partner if she fails  Duration of infertility and results of any previous to achieve pregnancy after 12 months or more of regular evaluation/treatment unprotected intercourse.
    [Show full text]